ALB and neoplasm: Ninety percent of the study populations showed signs of progressive disease throughout our observation, and the direction of longitudinal change in the parameters detailed in the Results section was towards the clinically worse conditions; e.g., it is known that increasing platelet count [70] or decreasing serum albumin [71] levels are poor prognostic signs and are related to an increased tumor burden.